CPH — Cipher Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$372.17m
- CA$391.96m
- $33.36m
- 85
- 50
- 78
- 82
Annual cashflow statement for Cipher Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.39 | 7.76 | 26.6 | 20.4 | 11.5 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.79 | 0.791 | 0.294 | 0.402 | 3.67 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.72 | 4.68 | -3.03 | -3.28 | 8.95 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 11.7 | 13.8 | 10.6 | 16 | 19.5 |
| Capital Expenditures | -0.76 | 0 | -0.081 | -0.144 | -80 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.76 | 0 | -0.081 | -0.144 | -80 |
| Financing Cash Flow Items | -0.163 | 0 | — | — | -0.469 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8.13 | -2.47 | -1.91 | -5.24 | 39.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.8 | 11.4 | 8.29 | 11 | -22 |